/
Chemical Resistance and Material Compatibility Testing/
ISO 10993-6 Local Effects after Chemical ExposureISO 10993-6 Local Effects after Chemical Exposure Laboratory Testing Service: A Comprehensive Guide
Standard-Related Information
The ISO 10993-6 standard is part of the ISO 10993 series, which provides guidelines for the biological evaluation of medical devices. The ISO 10993-6 standard specifically addresses the local effects after chemical exposure, providing a framework for assessing the potential harm caused by chemicals on human tissues.
Legal and Regulatory Framework
The ISO 10993-6 standard is widely recognized and adopted globally, with many countries incorporating it into their national regulations and standards. In the European Union, for example, the Medical Device Regulation (MDR) requires manufacturers to conduct biological evaluations in accordance with ISO 10993-6.
International and National Standards
Standard Development Organizations
The ISO 10993-6 standard is developed by Technical Committee 194, Biological Evaluation of Medical Devices (TC 194), which is responsible for developing and maintaining the ISO 10993 series. The TC 194 is composed of experts from various countries and industries.
Standards Evolution and Update
ISO standards are regularly reviewed and updated to reflect new scientific knowledge, technological advancements, and changing regulatory requirements. The ISO 10993-6 standard has undergone several revisions since its initial publication in 1992, with the latest version being published in 2016.
Standard Compliance Requirements
Compliance with the ISO 10993-6 standard is mandatory for medical device manufacturers that wish to demonstrate the safety and efficacy of their products. Failure to comply can result in regulatory penalties, product recalls, and damage to a companys reputation.
Why This Test Is Needed and Required
The ISO 10993-6 test is essential for assessing the potential harm caused by chemicals on human tissues. The test provides a critical evaluation of a medical devices safety profile, ensuring that it does not cause irritation or comedogenesis (pimple formation) to skin.
Business and Technical Reasons for Conducting ISO 10993-6 Testing
Conducting ISO 10993-6 testing provides numerous benefits to medical device manufacturers, including:
Test Conditions and Methodology
The ISO 10993-6 test involves a series of steps, including:
1. Sample Preparation: The medical device is prepared for testing by cleaning, disinfecting, or sterilizing it.
2. Testing Equipment and Instruments: Specialized equipment, such as dermatometers and comedogenicity meters, are used to assess skin irritation and comedogenesis potential.
3. Testing Environment Requirements: The test is conducted in a controlled environment with specific temperature, humidity, and pressure conditions.
4. Sample Application: The medical device is applied to the skin of an animal or human subject for a specified period.
5. Measurement and Analysis Methods: The skin irritation and comedogenesis potential are evaluated using standardized measurement techniques.
Test Reporting and Documentation
The test report includes:
Why This Test Should Be Performed
Performing the ISO 10993-6 test provides numerous benefits, including:
Why Eurolab Should Provide This Service
Eurolab has extensive expertise and experience in conducting ISO 10993-6 testing, with state-of-the-art equipment and facilities. Our qualified and certified personnel ensure that all tests are performed to the highest standards.
Conclusion
The ISO 10993-6 Local Effects after Chemical Exposure laboratory testing service is an essential tool for medical device manufacturers seeking to demonstrate product safety and efficacy. By understanding the standard-related information, requirements, and test conditions, manufacturers can make informed decisions about conducting this critical evaluation.